Market Cap (In TRY)
15.19 Billion
Revenue (In TRY)
11.33 Billion
Net Income (In TRY)
3.38 Billion
Avg. Volume
1.35 Million
- Currency
- TRY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 60.85-106.0
- PE
- -
- EPS
- -
- Beta Value
- -0.054
- ISIN
- TRADEVAW91E2
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Philipp Anthony Haas
- Employee Count
- -
- Website
- https://www.deva.com.tr
- Ipo Date
- 2000-05-10
- Details
- Deva Holding A.S. manufactures and sells pharmaceutical products in Turkey. The company provides antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also offers products in the areas of urogenital system and sex hormones, blood and blood forming organs, cardiovascular system, musculoskeletal system, nervous system, alimentary tract and metabolism, respiratory system, and sensory organs. In addition, the company offers cephalosporins, penicillin, inhalation products, solid and liquid oncology, animal health products, active pharmaceutical ingredients, ampoules, liquid and lyophilized vials, eye drops, medical ampoules for sterile injectable products, and cologne. It also exports its products to approximately 60 countries. The company was incorporated in 1958 and is based in Istanbul, Turkey. Deva Holding A.S. is a subsidiary of Eastpharma S.à R.L.
More Stocks
-
IRMENERGYIRM Energy Limited
IRMENERGY
-
AVLNF
-
ADT
-
FNCTFOrange S.A.
FNCTF
-
KWHAF
-
GLUCGlucose Health, Inc.
GLUC
-
2419
-
MAWANASUGMawana Sugars Limited
MAWANASUG